Modafinil for the treatment of
excessive daytime sleepiness in Parkinson's disease: a case report
Rabinstein A, Shulman LM, Weiner WJ.
Department of Neurology,
University of Miami School of Medicine,
1501 NW 9 Avenue,
33136, Miami, FL, USA
2001 Oct;7(4):287-288
ABSTRACT
We report a 59 year old woman
with levodopa responsive Parkinson's disease who developed excessive daytime
sleepiness [Epworth Sleepiness Scale (ESS) score of 13]. Treatment with
Modafinil 400mg daily within two weeks produced a subjective improvement in
her daytime sleepiness (ESS score after treatment is 8) with no significant
change in her PD motor symptomotology.
1. Modafinil for
sustaining the alertness of helicopter pilots
2. Modafinil augmentation
of antidepressant treatment
3. Modafinil the
unique properties of a new stimulant
4. Modafinil children
with attention-deficit/hyperactivity disorder
5. Modafinil dosage
and safety
6. Modafinil successful
treatment of hypersomnia & narcolepsy
7. Modafinil narcolepsy:
symptoms and management
8. Modafinil
amplification of cortical serotonin release
9. Modafinil
treatment of alcoholic organic brain syndrome
10. Modafinil
effect on melatonin, cortisol, and growth hormone
11. Modafinil
in obstructive sleep apnea-hypopnea syndrome
12. Modafinil
vs dextroamphetamine in treatment of adult ADHD
13. Modafinil
efficacy in narcolepsy
14. Modafinil
switching from narcolepsy drugs to modafinil
15. Modafinil
dopaminergic transmission mediates CNS stimu
